Adverse events12

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 12 of 12

Type	Event	Organ system	Group	Affected	At risk
other	hypoglycemia	Endocrine disorders	Nateglinide	1	24
other	hypoglycemia	Endocrine disorders	Glimepiride	0	23
other	dyspepsia	Gastrointestinal disorders	Nateglinide	2	24
other	dyspepsia	Gastrointestinal disorders	Glimepiride	0	23
other	gall stone	Gastrointestinal disorders	Nateglinide	1	24
other	gall stone	Gastrointestinal disorders	Glimepiride	0	23
other	herpes zoster	Skin and subcutaneous tissue disorders	Nateglinide	1	24
other	herpes zoster	Skin and subcutaneous tissue disorders	Glimepiride	0	23
other	gastritis	Gastrointestinal disorders	Nateglinide	1	24
other	gastritis	Gastrointestinal disorders	Glimepiride	0	23
other	dizziness	Nervous system disorders	Nateglinide	0	24
other	dizziness	Nervous system disorders	Glimepiride	1	23

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00858013/events